BACKGROUND
although many studies aim to understand the evolution of the human immunodeficiency virus  in its host  <cit>  there are still a lot of open questions related to the mechanisms driving the intra-host dynamics. one of these puzzles is associated with the hiv coreceptor switch  <cit> : to facilitate cell entry and subsequent replication hiv binds to the cell surface molecule cd <dig> as well as a chemokine coreceptor, most commonly the ccr <dig> or cxcr <dig> coreceptors. in most patients viruses that use the ccr <dig> coreceptor  dominate in early stages of disease. this preference changes however in about 50% of patients during the course of disease towards viruses using the cxcr <dig> coreceptor . this switch in coreceptor usage is associated with a worsened prognosis which makes a better understanding of the switch dynamics of direct clinical importance. at the same time there are several explanatory hypotheses but not yet a conclusive understanding of the underlying processes in terms of empirical evidence or model support. the transmission mutation hypothesis  <cit>  assumes that r <dig> viruses are favoured in transmission and are in consequence more often found in early infection. x <dig> viruses with higher fitness can emerge from r <dig> viruses via intermediate mutants of lower fitness which will finally become dominant  <cit> . while there is some evidence for a fitness loss of intermediate mutants  <cit> , this hypothesis strongly relies on the assumption that x <dig> viruses can hardly be transmitted in infectious doses as these would otherwise immediately become dominant due to their assumed selectional advantages in the host. there might be some strain selection during transmission but there is evidence that both r <dig> and x <dig> strains can be transmitted in infectious doses, however, with x <dig> viruses seemingly having a selectional disadvantage thereafter  <cit> . the effective replication rate of x <dig> viruses exceeds r <dig> replication in some in vitro assays  <cit> , there is, however, no conclusive picture of the in vivo situation with different environmental constraints  <cit> . taken this together  <cit> , it is highly questionable whether a fragile setting relying solely on the transmission mutation hypothesis adequately describes the major processes in place or robustly represents the observed dynamics.

an alternative and less fragile hypothesis assumes that environmental conditions in the host change during the course of disease in favour of x <dig> viruses. such changes may be the consequence of immune pressure or the availability of adequate target cells for replication in terms of receptor expression or replication efficiency by stage of cell development   <cit> . in a recent study sguanci and coworkers  <cit>  investigate the changing environment by assuming that the susceptibility of target cells  increases in favour of x <dig> cells as soon as these emerge in an auto-catalytic fashion, however, staying with the assumption that the initial infection is with r <dig> virus only. earlier work by wodarz et al.  <cit>  and callaway et al.  <cit>  allows more realistically for a mixed infection and investigates how the shift in target cells and hiv specific t cells can dynamically induce a shift from r <dig> to x <dig> viruses. in a similar fashion, ribeiro et al. investigate how the coreceptor switch can be facilitated due to preferential replication of x <dig> and r <dig> viruses in naive and memory t cells, respectively, with differences in efficiency of viral reproduction  <cit> . these approaches support the hypothesis of environmental change as a driving force to the coreceptor switch but do not consider the stochastic nature of virus evolution and the emergence of new strains and viral diversity which have been associated with the coreceptor switch. while the relative importance of the above hypotheses for the coreceptor switch can ultimately only be answered experimentally we will here focus on the more robust hypothesis of environmental change for further analysis. we want to identify key processes resulting in the observed phenomenon by a restriction to a minimal model representing the dynamics of the immune system and hiv  <cit> . therefore, we develop an approach based on the well studied model of nowak and may  <cit>  that allows to study the dynamical processes associated with the hiv coreceptor switch in combination with viral evolution. while we do not go yet into the details of cellular subpopulations whose roles are empirically still under debate we rather take advantage of the relative simplicity of the model to study the effects of the stochastic nature of hiv evolution neglected in the models outlined above. the stochastic framework will allow to analyse the distribution of evolutionary pathways associated with the coreceptor switch as well as survival times in a more systematic way.

it has specifically become of major importance to understand the processes leading to the dominance of x <dig> viruses since new drugs have been licensed that block the ccr <dig> receptor  <cit>  and in consequence can shift the selective advantage towards x <dig> viruses  <cit> , although not necessarily inducing a coreceptor switch. considering the association between x <dig> viruses and a worsened prognosis  <cit>  it is of vital importance to understand whether x <dig> can only flourish in the environment of a patient weakened by side effects of a chronic infection or whether x <dig> viruses themselves destabilise the patient and cause the worsened prognosis  <cit> .

RESULTS
the model
following the ansatz of nowak and may  <cit>  we study the time evolution of viral load vi of a set of n strains . these are controlled by a specific immune response with strength xi and as well as a cross-reactive immune response with strength z. their time evolution is determined by the following set of equations:

with variables and parameters as summarised in table  <dig> 

v
                              i
x
                              i
r
                              i
u
                              i
the viral load of strain i grows at a rate ri and is diminished by the specific and cross-reactive immune response at a rate -pixi - qiz. vice versa, a specific immune response is stimulated by each strain as is the cross-reactive immunity by the total viral load. immune responses decay at a rate b and further at a rate proportional to the viral load which is to account for the fact that hiv infected t helper cells are depleted . among the 2n possible equilibrium solutions of a set of equations  for n strains at most one is stable  <cit> , that is, for any number of strains the viral load either diverges or converges to a well defined equilibrium viral load. strains are distinguished by their sensitivity towards the specific immune response, i.e. several related genomic sequences might represent the same epitope and consequently correspond to one strain in the model. the model does not yet address the question of different immune cell populations as for example cd <dig> vs. cd <dig> cells, naive vs. memory cells or resting vs. replicating cells. the distinction between xi and z takes only into account that there is a strain specific and an unspecific component of the immune response. the latter can be a composition of the response towards conserved parts of the virus, of cross-reactivity from earlier specific immune responses or innate immunity. bare of any strain-specific responsiveness, z is a measure for the general activation of the immune system going along with an overall turnover of cd <dig> cells  seen in hiv infections  <cit> .

to focus on the evolution of r <dig> and x <dig> viruses in a patient we distinguish only between two parameter sets corresponding to either type of virus as listed in table  <dig>  the values of initial viral growth rates are estimated from  <cit> . however, viral growth rates or more generally viral fitness as the balance between viral replication and decay is not an intrinsic feature of the virus but is only well defined in the context of the viruses environmental conditions. differences in viral fitness may therefore arise among viruses and over time with a change of environmental conditions such as the availability of target cells or the strength of an immune response. here, we assume that x <dig> viruses are better recognised by the specific immune response than r <dig> viruses  <cit>  and increase their replication rate proportional to the stimulation and activation of the immune system  <cit>  represented by the cross-reactive immunity z. while the cumulative immune activation z will likely impact on both r <dig> and x <dig> viral replication  <cit>  we are only interested in the increase of x <dig> replication over r <dig> replication and therefore keep the r <dig> replication rate fixed. the cumulative immune activation z increases slightly during the course of disease and breaks only down with the collapse of the immune system at the onset of aids. the chosen parameter set corresponds to a situation in which the viral load can initially be controlled by the immune response, i.e. a situation in which limitations in target cell supplies or other saturation phenomena do not have to be taken into account. the model's dynamics is robust with respect to the choice of further parameters as long as they correspond to the model's regime of hiv-like dynamics ).

parameter settings for r <dig> and x <dig> viruses, the values chosen in the simulations are given in brackets in units per day  and viral load , due to the close genetic neighbourhood of r <dig> and x <dig> viruses it is assumed that both mutants occur with the same probability  from the total viral population irrespective of its composition. where direct biological interpretation is possible parameters have been chosen following  <cit> , remaining degrees of freedom have been fixed to account for the appropriate dynamical regime defined by equation . note that the growth rate of x <dig> viruses is assumed to increase proportional to the immune activation measured by the cross reactive immunity z with Î± =  <dig> .

the model system is initialised with a strain of r <dig> virus and a strain of x <dig> virus and evolves according to equations . a new mutant arises at a hazard rate pmv, i.e. at each integration step of length dt with probability . in the current setting, x <dig> and r <dig> mutants are assumed to arise with equal probability irrespective of the composition of the viral load due to the close genetic neighbourhood of these viral subtypes  <cit>  . after the emergence of each new mutant the system reaches a new equilibrium with nr <dig> r <dig> virus strains and nx <dig> x <dig> virus strains and viral load

the system is stable, i.e. there is a stable equilibrium solution only if

 <dig>  ru <kq, i.e. the viral load is fully controlled by the cross reactive immune response z alone or

 <dig> 

that is, only as long as the numbers of r <dig> and x <dig> virus strains do not exceed the critical numbers given by condition  the immune system can control the infection.

we are specifically interested in dynamical regimes of the model which remain only stable for finite numbers of r <dig> and x <dig> virus strains  but do not show immediate divergence  > 0) which corresponds to

the first inequality in  implies that the cross-reactive immune response cannot fully control the viral infection as can be seen from equation . this means that each viral strain needs to be suppressed both by a specific and a cross-reactive immune response. the second inequality implies that the immune system can control only a limited number of strains, i.e. the limitations of the cross-reactive immune response can be compensated by the specific immune response if the critical number of strains given by equation  is not exceeded. as soon as this number of strains is exceeded this will lead to an uncontrolled increase in viral load in the model corresponding to the onset of aids in the patient  <cit> . the detailed dynamics in this regime are not longer described by equations  as saturation effects have to be considered due to limited resources.

the emergence of viral strains in a patient that accumulate to the critical number at the onset of aids can also be understood in a probabilistic framework in order to study survival distributions. therefore we derive the probability p that a patient harbours nr <dig> strains of r <dig> virus and nx <dig> strains of x <dig> virus at time t. if the viral load equilibrates much faster after the emergence of a new mutant than the next mutant arises we can assume that new mutants will approximately arise at a rate proportional to the equilibrium viral load v. in the regime where  and v <vmax the evolution of the number of viral strains is then described by a markov process with the master equation  <cit> 

for those states in which the critical number of strains given by equation  or a maximal viral load vmax is exceeded, i.e. at the onset of aids, the last term in equation  is defined to vanish making these states absorbing states of the markov process. vmax limits the diverging viral load v as the total viral load in the patient is limited. the distribution of times until absorption, i.e. the survival distributions, are described by phase type distributions  <cit> .

the course of disease
first insight into the evolutionary dynamics of r <dig> and x <dig> viruses can be gained by investigating the time course of viral load attributed to each subtype in the model. such a typical course of disease after a mixed infection with r <dig> and x <dig> viruses in the model is shown in fig.  <dig> 

the system shows a period of low viral load after the initial phase of disease with is interspersed with small outbreaks when a new viral mutant occurs - until eventually the viral load rises again. the system shows a quasi-stable behaviour as long as inequality  can be fulfilled for a non-zero but limited number of strains, i.e. if inequality  holds.

x <dig> viruses are underrepresented in viral load in the early stages of disease as the model assumes that they are more strongly suppressed by the specific immune response than r <dig> viruses   <cit>  while having initially identical growth rates  <cit> . on the other hand the x <dig> replication rate in the model increases proportional to the overall activation of the immune system represented by the cross-reactive immune response. this shifts fitness advantages from r <dig> viruses to x <dig> viruses resulting in the phenomenology of a coreceptor switch.

the model captures the association between ongoing immune activation and the apparent shift in evolutionary advantages from r <dig> to x <dig> viruses during an hiv infection. there is however still controversy about the mechanisms underlying this association. earlier assumptions about a shift in target cells favouring x <dig> over r <dig> viruses  <cit>  are now questioned  <cit> . an alternative hypothesis links the efficiency of viral production to the division rate of target cells  <cit> . with the differential increase in target cell division rates during chronic infection  <cit>  viral replication rates are differentially increased which eventually shifts the selectional advantage from r <dig> viruses to x <dig> viruses  <cit> . another interpretation of the model equations is that x <dig> viruses experience a stronger specific immune response than r <dig> viruses but that they face a reduced cross-reactive immune response. in consequence x <dig> viruses will be more difficult to control as the number of strains grows. any of these hypotheses allows for a dynamical change in environmental conditions in the host that become more favourable for x <dig> viruses after chronic infection while selection is in favour of r <dig> viruses in early stages of disease. although, there is some evidence  <cit>  in accordance with the model's assumptions on parameter settings it is difficult to get conclusive results from currently available empirical data. many studies with one or only a few hiv or siv cases point in different directions : any comparative measurement of growth rates and the effect of an immune response among strains in vivo assesses quantities derived from a large variety of underlying processes that might vary among cases. therefore, a more conclusive picture can only be expected with the integration of more data describing the interactions between hiv and the immune system in many patients. the observation that some viral strains may be present in a patient for a long time before they appear in detectable numbers favours the idea of a dynamical change in the environmental conditions in favour of x <dig> viruses  <cit>  at a higher level of abstraction. reflecting these findings, the current model provides a coarse grained picture of possible scenarios for environmental shifts in the patient for further investigation. while details of these dynamics will have to be addressed within a refined model the current model has the advantage to be accessible to further analysis of the basic underlying stochastic processes as demonstrated in the following sections.

the routes of evolution
the probabilistic framework complementarily allows to study the probability to find a setting with nr <dig> r <dig> strains and nx <dig> x <dig> strains in a patient at any time during the course of disease - including the probability to have reached the final stage of disease, i.e. having exceeded the critical number of strains.

fig.  <dig> shows that a patient is most likely to be found either with a few strains or in a situation in which the final stage of disease has already been reached. this is due to the fact that the viral load and in consequence the probability to generate new mutants increases with a growing burden of viral strains. as a result the mean residence time with a given number of strains  will decrease as the number of strains grows, i.e. the course of disease speeds up with the accumulation of viral strains. the distribution of strain compositions shown in fig.  <dig> is asymmetric with respect to the numbers of r <dig> and x <dig> strains in the presence of a moderate number of strains, i.e. in a stage of disease that is not yet progressed. a moderate number of strains will not result in strong stimulation of the immune system and x <dig> replication and viral load remain at a low level compared to the contribution of r <dig> strains. x <dig> strains will consequently not drive the course of disease as much ahead as r <dig> strains in early stages of disease. therefore the model predicts that non-progressors may even have more x <dig> strains than r <dig> strains without experiencing a coreceptor switch. the intricate dependency of the coreceptor switch on the numbers and composition of strains is analysed in detail in the following section.

the coreceptor switch
the coreceptor switch is a phenomenological observation for which a corresponding process has to be characterised in our model. as the simulations start with a dominance of r <dig> viruses due to the bias in immune recognition  we define that a coreceptor switch has occurred if the viral load is dominated by x <dig> viruses at the onset of aids which is determined in the model by either exceeding a viral load vmax or the critical numbers of strains nr <dig> and nx <dig> . from

it can be seen that it depends on the number and composition of viral strains in the system which type of virus dominates, i.e. when the trade-off between replication rate and sensitivity to the immune response favours x <dig> viruses. x <dig> viral load dominates in a patient who has not yet reached the terminal stage of disease if

which corresponds to the area shaded in red in fig.  <dig>  in early infection x <dig> strains do not impose a high viral load and the number of x <dig> strains required to dominate the viral population in the presence of r <dig> viruses is usually not found in a patient. this picture changes in late infection where a smaller fraction of x <dig> strains among all strains can be sufficient for dominance in in viral load. this can be seen in fig.  <dig> which shows graphically what strain composition leads to a dominance in x <dig> viral load  and when the system is destabilised indicating the onset of aids . the saturation behaviour of equation  implies that dominance of x <dig> viruses in viral load can be attained with a minority of x <dig> strains as soon as

note that this situation is only observed in the latent phase defined by equation  if x <dig> viruses gain sufficiently fast replicative fitness, i.e. .

within the model the occurrence of a coreceptor switch depends on the probabilistically chosen evolutionary path in the patient  - i.e. whether a path is chosen that leads directly to destabilisation and aids or whether the final stage is reached after a switch in coreceptor usage. the probabilities for either choice are shown in fig.  <dig>  it shows that for any newly infected patient the probabilities of eventually reaching the final stage of disease with dominance of r <dig> viruses or x <dig> viruses are of the same order of magnitude with the parameter set chosen in in table  <dig>  dominance of x <dig> viruses is only possible with a certain amount of strains and immune activation being established and is therefore associated with an increased number of strains and a progressed stage of disease.

the results from the probabilistic approach considering equilibrium viral load according to equation  are compared with survival curves sampled from simulations of equations  based on the actual viral load. the good agreement shows that the flow of mutants is strongly determined by the equilibrium viral load .

as the average time to the onset of aids as well as the mean residence times in a given stage decrease with the accumulation of mutant strains ) patients with dominance in x <dig> viral load have a worsened prognosis in this respect. the higher burden in viral load associated with the higher number of strains leads to an accelerated progression of disease  and figs.  <dig> and 3).

note that suppression of r <dig> viruses as facilitated by coreceptor blockers  <cit>  does not only reduce r <dig> viral load in the model but also diminishes the x <dig> viral load due to reduced immune activation .

CONCLUSIONS
a mechanistic assessment of the processes leading to the coreceptor switch in hiv infected patients is difficult - and maybe even inadequate - due to the large variability and stochasticity of the underlying processes in vivo. quantities such as viral growth or clearance rates are often only known in very specific settings without detailed knowledge of possible hidden dependencies from the underlying dynamical processes - and can in consequence point in contradictory directions. the observation that certain hiv strains may be present in a patient for a long time before they grow to a detectable viral load  <cit>  hints however towards a picture of a dynamical change in the environmental conditions in the host. this holds specifically for x <dig> viruses  <cit> .

the current model provides a coarse grained, probabilistic picture of possible dynamical scenarios of the coreceptor switch without going yet into the details of virus replication and immune response. this allows to study the basic dynamical features and conditions for a coreceptor switch. in the model, the viral quasispecies  <cit>  is generated by a probabilistic process under the pressure of the immune system. its composition depends on the randomly chosen evolutionary path that may show some biases due to environmental conditions. these include the viral replication efficiencies based on adequate target cells as well as constraints of immune recognition or therapy. the answer to the question whether a coreceptor switch has occurred is determined by the composition of the viral quasispecies found at the time when the host's immune system loses control and the viral load diverges, i.e. at the onset of aids in the model system. one prediction is that the suppression of r <dig> viruses in the host will not necessarily result in an expansion of x <dig> viruses. the control of r <dig> viruses can even delay or prevent the emergence of considerable x <dig> viral load - which strongly depends on the constitution of the host, i.e. in biases in the choice of the possible evolutionary paths. this is well in accordance with the studies done for a newly licensed drug which blocks the ccr <dig> receptor  <cit> . the model provides a stochastic framework to investigate r <dig> and x <dig> virus evolution in a dynamic environment, however staying with a qualitative description of the cellular processes. this is a strong simplification of the complex interaction network that interlinks hiv and the hosts immune system. the growing knowledge about their interactions  <cit>  will be implemented within a refined model. this should combine the advantages of this stochastic approach with more details on the involved immune cells populations - both with regard to their role in the immune response and their contribution to persistent immune activation and viral replication - to allow for more quantitative predictions.

